{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:21:33Z","timestamp":1793316093413,"version":"4.5.0"},"reference-count":64,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n                  <jats:p>Mucins are essential components of the ocular surface, ensuring epithelial protection, tear film stability, and immune regulation. Mucin deficiency contributes to a spectrum of ocular surface disorders, including dry eye disease, allergic conjunctivitis, and cicatricial conditions such as Stevens\u2013Johnson syndrome and ocular graft-versus-host disease. This review outlines current knowledge of mucin biology, regulatory mechanisms, and emerging therapeutic applications of mucin secretagogues in ocular surface disorders. Signaling cascades involving EGFR activation, MAPK phosphorylation, cholinergic and adrenergic stimulation, and cytokine-mediated modulation (e.g., interleukin-13, tumor necrosis factor-\u03b1) govern mucin transcription and goblet cell function. Clinically approved secretagogues such as diquafosol and rebamipide improve mucin expression and epithelial healing, while biologics, gene therapies, and nutraceutical compounds are actively being explored. Advancing these therapies may enable more targeted and durable restoration of ocular surface integrity across a range of mucin-deficient diseases. We searched for related research on PubMed using the terms \u201cMucin\u201d and \u201cMucin secretagogues,\u201d along with keywords such as \u201cdry eye,\u201d \u201cgoblet cell,\u201d and \u201cocular surface disorder.\u201d Articles related to mucin secretagogues published within the last 10 years were reviewed.<\/jats:p>","DOI":"10.4103\/tjo.tjo-d-25-00105","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T13:01:17Z","timestamp":1765198877000},"page":"535-544","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Restoring the mucin barrier: Advances in secretagogue therapies for ocular surface disorders"],"prefix":"10.4103","volume":"15","author":[{"given":"Ya-Ning","family":"Chuang","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Taipei Tzu Chi Hospital, The Buddhist Tzu Chi Medical Foundation, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiu-Hui","family":"Hsieh","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Taipei Tzu Chi Hospital, The Buddhist Tzu Chi Medical Foundation, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Hsin","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Medicine, Taipei Medical University, Taipei, Taiwan"},{"name":"Department of Medical Education, Taipei Tzu Chi Hospital, The Buddhist Tzu Chi Medical Foundation, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Feng","family":"Hung","sequence":"additional","affiliation":[{"name":"Department of Medical Research, Taipei Veterans General Hospital, Taipei, Taiwan"},{"name":"Department of Dentistry, School of Dentistry, National Yang-Ming Chiao Tung University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Cherng","family":"Hsu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Taipei Tzu Chi Hospital, The Buddhist Tzu Chi Medical Foundation, Taipei, Taiwan"},{"name":"School of Medicine, Tzu-Chi University, Hualien, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Chen","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Taipei Tzu Chi Hospital, The Buddhist Tzu Chi Medical Foundation, Taipei, Taiwan"},{"name":"School of Medicine, Tzu-Chi University, Hualien, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,12,8]]},"reference":[{"key":"R1-20251223","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jtos.2021.03.003","article-title":"Membrane-associated mucins of the human ocular surface in health and disease","volume":"21","author":"Martinez-Carrasco","year":"2021","journal-title":"Ocul Surf"},{"issue":"Suppl 1","key":"R2-20251223","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s12886-015-0137-5","article-title":"Ocular surface mucins and local inflammation \u2013Studies in genetically modified mouse lines","volume":"15","author":"Shirai","year":"2015","journal-title":"BMC Ophthalmol"},{"key":"R3-20251223","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.preteyeres.2018.11.007","article-title":"Reconsidering the central role of mucins in dry eye and ocular surface diseases","volume":"71","author":"Baudouin","year":"2019","journal-title":"Prog Retin Eye Res"},{"key":"R4-20251223","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1136\/bjo.2010.199901","article-title":"Minor salivary glands and labial mucous membrane graft in the treatment of severe symblepharon and dry eye in patients with Stevens-Johnson syndrome","volume":"96","author":"Sant'Anna","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"R5-20251223","first-page":"299","article-title":"Conjunctival goblet cell density in normal subjects and in dry eye syndromes","volume":"14","author":"Ralph","year":"1975","journal-title":"Invest Ophthalmol"},{"key":"R6-20251223","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.exer.2003.10.005","article-title":"Control of mucin production by ocular surface epithelial cells","volume":"78","author":"Dartt","year":"2004","journal-title":"Exp Eye Res"},{"key":"R7-20251223","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s12886-023-02931-3","article-title":"Comparison of mucin levels at the ocular surface of visual display terminal users with and without dry eye disease","volume":"23","author":"Duan","year":"2023","journal-title":"BMC Ophthalmol"},{"key":"R8-20251223","doi-asserted-by":"crossref","first-page":"S151","DOI":"10.1167\/iovs.17-23623","article-title":"Secreted mucins on the ocular surface","volume":"59","author":"Hori","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R9-20251223","doi-asserted-by":"crossref","first-page":"e0174764","DOI":"10.1371\/journal.pone.0174764","article-title":"Preclinical mouse model to monitor live Muc5b-producing conjunctival goblet cell density under pharmacological treatments","volume":"12","author":"Portal","year":"2017","journal-title":"PLoS One"},{"key":"R10-20251223","doi-asserted-by":"crossref","first-page":"e50704","DOI":"10.1371\/journal.pone.0050704","article-title":"Mucin deficiency causes functional and structural changes of the ocular surface","volume":"7","author":"Floyd","year":"2012","journal-title":"PLoS One"},{"key":"R11-20251223","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/00003226-200301000-00010","article-title":"MUC7 expression in the human lacrimal gland and conjunctiva","volume":"22","author":"Jumblatt","year":"2003","journal-title":"Cornea"},{"key":"R12-20251223","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/rr43","article-title":"Role of epidermal growth factor receptor activation in regulating mucin synthesis","volume":"2","author":"Nadel","year":"2001","journal-title":"Respir Res"},{"key":"R13-20251223","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.preteyeres.2016.04.005","article-title":"Goblet cells of the conjunctiva:A review of recent findings","volume":"54","author":"Gipson","year":"2016","journal-title":"Prog Retin Eye Res"},{"key":"R14-20251223","doi-asserted-by":"crossref","first-page":"1384500","DOI":"10.3389\/fmed.2024.1384500","article-title":"Elucidating the mechanism of corneal epithelial cell repair:Unraveling the impact of growth factors","volume":"11","author":"Gong","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"R15-20251223","doi-asserted-by":"crossref","first-page":"108715","DOI":"10.1016\/j.celrep.2021.108715","article-title":"Generation of functional conjunctival epithelium, including goblet cells, from human iPSCs","volume":"34","author":"Nomi","year":"2021","journal-title":"Cell Rep"},{"key":"R16-20251223","first-page":"2789","article-title":"Fibroblast growth factor 10 upregulates the expression of mucins in rat conjunctival epithelial cells","volume":"17","author":"Ma","year":"2011","journal-title":"Mol Vis"},{"key":"R17-20251223","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.exer.2012.08.010","article-title":"Signaling pathways used by EGF to stimulate conjunctival goblet cell secretion","volume":"103","author":"Hodges","year":"2012","journal-title":"Exp Eye Res"},{"key":"R18-20251223","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/mi.2015.53","article-title":"Interaction of IFN-\u03b3 with cholinergic agonists to modulate rat and human goblet cell function","volume":"9","author":"Garc\u00eda-Posadas","year":"2016","journal-title":"Mucosal Immunol"},{"key":"R19-20251223","doi-asserted-by":"crossref","first-page":"4186","DOI":"10.1167\/iovs.14-15496","article-title":"IL-13 stimulates proliferation and expression of mucin and immunomodulatory genes in cultured conjunctival goblet cells","volume":"56","author":"Tukler Henriksson","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R20-20251223","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1167\/iovs.18-25964","article-title":"The protective effect of a topical mucin secretagogue on ocular surface damage induced by airborne carbon black exposure","volume":"60","author":"Li","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R21-20251223","doi-asserted-by":"crossref","first-page":"636812","DOI":"10.1155\/2013\/636812","article-title":"Modulation of conjunctival goblet cell function by inflammatory cytokines","volume":"2013","author":"Contreras-Ruiz","year":"2013","journal-title":"Mediators Inflamm"},{"key":"R22-20251223","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1089\/10807680260218524","article-title":"INS365 suppresses loss of corneal epithelial integrity by secretion of mucin-like glycoprotein in a rabbit short-term dry eye model","volume":"18","author":"Fujihara","year":"2002","journal-title":"J Ocul Pharmacol Ther"},{"key":"R23-20251223","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/cei.12759","article-title":"Desiccating stress-induced disruption of ocular surface immune tolerance drives dry eye disease","volume":"184","author":"Guzm\u00e1n","year":"2016","journal-title":"Clin Exp Immunol"},{"key":"R24-20251223","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.1038\/s41598-019-39467-w","article-title":"Enriched environment alleviates stress-induced dry-eye through the BDNF axis","volume":"9","author":"Sano","year":"2019","journal-title":"Sci Rep"},{"key":"R25-20251223","doi-asserted-by":"crossref","first-page":"e412","DOI":"10.1111\/aos.13526","article-title":"Dry eye disease and oxidative stress","volume":"96","author":"Seen","year":"2018","journal-title":"Acta Ophthalmol"},{"key":"R26-20251223","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1089\/jop.2011.0142","article-title":"Rebamipide increases the mucin-like glycoprotein production in corneal epithelial cells","volume":"28","author":"Takeji","year":"2012","journal-title":"J Ocul Pharmacol Ther"},{"key":"R27-20251223","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1358\/dnp.2008.21.3.1203413","article-title":"Therapeutic targets in dry eye syndrome","volume":"21","author":"Peral","year":"2008","journal-title":"Drug News Perspect"},{"key":"R28-20251223","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1136\/bjo.86.12.1412","article-title":"Commensal ocular bacteria degrade mucins","volume":"86","author":"Berry","year":"2002","journal-title":"Br J Ophthalmol"},{"key":"R29-20251223","doi-asserted-by":"crossref","first-page":"107724","DOI":"10.1016\/j.exer.2019.107724","article-title":"Ocular mucins in dry eye disease","volume":"186","author":"Portal","year":"2019","journal-title":"Exp Eye Res"},{"key":"R30-20251223","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jtos.2017.05.011","article-title":"TFOS DEWS II pathophysiology report","volume":"15","author":"Bron","year":"2017","journal-title":"Ocul Surf"},{"key":"R31-20251223","first-page":"250","article-title":"Biomarkers of ocular allergy and dry eye disease","volume":"67","author":"Zemba","year":"2023","journal-title":"Rom J Ophthalmol"},{"key":"R32-20251223","doi-asserted-by":"crossref","first-page":"106206","DOI":"10.1016\/j.ejps.2022.106206","article-title":"Current trends in pharmaceutical treatment of dry eye disease:A review","volume":"175","author":"Mohamed","year":"2022","journal-title":"Eur J Pharm Sci"},{"key":"R33-20251223","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1111\/all.15174","article-title":"Epithelial barrier dysfunction in ocular allergy","volume":"77","author":"Singh","year":"2022","journal-title":"Allergy"},{"key":"R35-20251223","first-page":"350","article-title":"Cytokines in allergic conjunctivitis:Unraveling their pathophysiological roles","volume":"14","author":"Chigbu","year":"2024","journal-title":"Life (Basel)"},{"key":"R36-20251223","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.aopr.2024.01.006","article-title":"Efficacy of 3% diquafosol combined with azelastine hydrochloride in allergic conjunctivitis patients with dry eye","volume":"4","author":"Lin","year":"2024","journal-title":"Adv Ophthalmol Pract Res"},{"key":"R37-20251223","doi-asserted-by":"crossref","first-page":"23037","DOI":"10.1074\/jbc.M109.033332","article-title":"Association of cell surface mucins with galectin-3 contributes to the ocular surface epithelial barrier","volume":"284","author":"Arg\u00fceso","year":"2009","journal-title":"J Biol Chem"},{"key":"R38-20251223","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1463-5224.2004.00325.x","article-title":"The tear film and ocular mucins","volume":"7","author":"Davidson","year":"2004","journal-title":"Vet Ophthalmol"},{"key":"R39-20251223","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00347-015-0006-x","article-title":"Adenoviral keratoconjunctivitis","volume":"112","author":"Pleyer","year":"2015","journal-title":"Ophthalmologe"},{"key":"R40-20251223","doi-asserted-by":"crossref","first-page":"e00112","DOI":"10.1128\/mSphere.00112-15","article-title":"Epidemic keratoconjunctivitis-causing adenoviruses induce MUC16 ectodomain release to infect ocular surface epithelial cells","volume":"1","author":"Menon","year":"2016","journal-title":"mSphere"},{"key":"R41-20251223","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4103\/ijo.IJO_870_16","article-title":"Chlamydial eye infections:Current perspectives","volume":"65","author":"Satpathy","year":"2017","journal-title":"Indian J Ophthalmol"},{"key":"R42-20251223","doi-asserted-by":"crossref","first-page":"e0007559","DOI":"10.1371\/journal.pntd.0007559","article-title":"Ocular immune responses, Chlamydia trachomatis infection and clinical signs of trachoma before and after azithromycin mass drug administration in a treatment na\u00efve trachoma-endemic Tanzanian community","volume":"13","author":"Ramadhani","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"R43-20251223","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1007\/s40123-023-00725-w","article-title":"Ophthalmic aspects of Stevens-Johnson syndrome and toxic epidermal necrolysis:A narrative review","volume":"12","author":"T\u00f3th","year":"2023","journal-title":"Ophthalmol Ther"},{"key":"R44-20251223","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ajo.2016.03.020","article-title":"Ocular manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis in children","volume":"166","author":"Catt","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"R45-20251223","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s12026-019-09087-7","article-title":"Ocular mucous membrane pemphigoid:A review","volume":"67","author":"Taurone","year":"2019","journal-title":"Immunol Res"},{"key":"R46-20251223","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jtos.2019.11.005","article-title":"Conjunctival goblet cells:Ocular surface functions, disorders that affect them, and the potential for their regeneration","volume":"18","author":"Swamynathan","year":"2020","journal-title":"Ocul Surf"},{"key":"R47-20251223","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.survophthal.2023.02.006","article-title":"Ocular graft-versus-host disease (oGVHD):From A to Z","volume":"68","author":"Soleimani","year":"2023","journal-title":"Surv Ophthalmol"},{"key":"R48-20251223","doi-asserted-by":"crossref","first-page":"114582","DOI":"10.1016\/j.addr.2022.114582","article-title":"Novel drug delivery systems for the management of dry eye","volume":"191","author":"Nagai","year":"2022","journal-title":"Adv Drug Deliv Rev"},{"key":"R49-20251223","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s40265-015-0409-7","article-title":"Diquafosol ophthalmic solution 3%:A review of its use in dry eye","volume":"75","author":"Keating","year":"2015","journal-title":"Drugs"},{"key":"R50-20251223","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1136\/bjophthalmol-2014-305425","article-title":"Inhibition by rebamipide of cytokine-induced or lipopolysaccharide-induced chemokine synthesis in human corneal fibroblasts","volume":"98","author":"Fukuda","year":"2014","journal-title":"Br J Ophthalmol"},{"key":"R51-20251223","doi-asserted-by":"crossref","first-page":"529","DOI":"10.5301\/EJO.2011.6294","article-title":"Pentoxifylline (anti-tumor necrosis factor drug):Effective adjuvant therapy in the control of ocular cicatricial pemphigoid","volume":"21","author":"El Darouti","year":"2011","journal-title":"Eur J Ophthalmol"},{"key":"R52-20251223","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1080\/17512433.2018.1449642","article-title":"Dupilumab for treatment of atopic dermatitis","volume":"11","author":"Seegr\u00e4ber","year":"2018","journal-title":"Expert Rev Clin Pharmacol"},{"key":"R53-20251223","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1111\/all.15717","article-title":"Dupilumab-associated ocular surface disease in atopic dermatitis patients:Clinical characteristics, ophthalmic treatment response and conjunctival goblet cell analysis","volume":"78","author":"Achten","year":"2023","journal-title":"Allergy"},{"key":"R54-20251223","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1167\/tvst.9.3.29","article-title":"Dupilumab-associated mucin deficiency (DAMD)","volume":"9","author":"Barnett","year":"2020","journal-title":"Transl Vis Sci Technol"},{"key":"R55-20251223","doi-asserted-by":"crossref","first-page":"14054","DOI":"10.1038\/s41598-020-70944-9","article-title":"Dry eye in rheumatoid arthritis patients under TNF-inhibitors:Conjunctival goblet cell as an early ocular biomarker","volume":"10","author":"Usuba","year":"2020","journal-title":"Sci Rep"},{"key":"R56-20251223","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s40265-020-01289-w","article-title":"Cenegermin:A review in neurotrophic keratitis","volume":"80","author":"Deeks","year":"2020","journal-title":"Drugs"},{"key":"R57-20251223","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00417-004-0955-2","article-title":"Efficacy of topical nerve growth factor treatment in dogs affected by dry eye","volume":"243","author":"Coassin","year":"2005","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R58-20251223","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1001\/archopht.1975.01010020815015","article-title":"Clinical experience with a mobile ocular perfusion pump","volume":"93","author":"Ralph","year":"1975","journal-title":"Arch Ophthalmol"},{"key":"R59-20251223","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.4103\/IJO.IJO_2756_22","article-title":"Autologous serum eye drops in dry eye disease:Preferred practice pattern guidelines","volume":"71","author":"Vazirani","year":"2023","journal-title":"Indian J Ophthalmol"},{"key":"R60-20251223","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/ICO.0000000000000726","article-title":"Effects of autologous serum eye drops on conjunctival expression of MUC5AC in patients with ocular surface disorders","volume":"35","author":"L\u00f3pez-Garc\u00eda","year":"2016","journal-title":"Cornea"},{"key":"R61-20251223","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1080\/02713683.2019.1607394","article-title":"Changes in corneal expression of MUC5AC after autologous serum eyedrop treatment in patients with limbal stem cell deficiency","volume":"44","author":"L\u00f3pez-Garc\u00eda","year":"2019","journal-title":"Curr Eye Res"},{"key":"R62-20251223","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.4103\/IJO.IJO_2789_22","article-title":"Omega-3 fatty acids supplements for dry eye \u2013Are they effective or ineffective?","volume":"71","author":"Bhargava","year":"2023","journal-title":"Indian J Ophthalmol"},{"key":"R63-20251223","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.3390\/nu13061998","article-title":"A review of topical and systemic vitamin supplementation in ocular surface diseases","volume":"13","author":"Fogagnolo","year":"2021","journal-title":"Nutrients"},{"key":"R64-20251223","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0014-4835(03)00084-8","article-title":"The role of calcium in mucin packaging within goblet cells","volume":"77","author":"Paz","year":"2003","journal-title":"Exp Eye Res"},{"key":"R65-20251223","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/aos.14470","article-title":"Vitamin D deficiency is associated with dry eye syndrome:A systematic review and meta-analysis","volume":"98","author":"Liu","year":"2020","journal-title":"Acta Ophthalmol"}],"container-title":["Taiwan Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/tjo.TJO-D-25-00105","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:53:38Z","timestamp":1786647218000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/tjo.TJO-D-25-00105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":64,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/tjo.tjo-d-25-00105","relation":{},"ISSN":["2211-5056","2211-5072"],"issn-type":[{"value":"2211-5056","type":"print"},{"value":"2211-5072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"2025-06-28","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-19","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}